Short Bio
Biocon is a global biopharmaceutical company. Bengaluru, India is home to the major biopharmaceutical business Biocon. Kiran Mazumdar-Shaw, a biochemist and businessman, created it in 1978. In addition to developing and producing generic medications, insulin, and APIs, Biocon is a market leader in the production of biosimilars worldwide. The business places a high priority on research and development, and it is currently developing a pipeline of cutting-edge products. Biocon is dedicated to giving patients all over the world access to affordable healthcare. Biocon Biologics Limited (BBL) is a wholly owned subsidiary of Biocon Limited. BBL is a leading global biosimilars company with a portfolio of biosimilars approved in the US, Europe, and other markets.
Overview
Company Name: | Biocon Limited |
Also Know as: | Biocon |
Type: | Biopharmaceutical company |
Industry: | Healthcare |
Founded: | 1978 |
Founders: | Kiran Mazumdar-Shaw |
organization: | N/A |
Headquarters: | Bengaluru, India |
Area Served: | Worldwide |
Revenue: | INR 14,249 crores (USD 1.85 billion) |
Net Income: | INR 2,257 crores (USD 300 million) |
Number of Employees: | 12,000+ |
Website: | https://www.biocon.com/ |
History
Kiran Mazumdar-Shaw, a biochemist and entrepreneur, created Biocon in 1978. The business started out as a modest fermentation facility but has now developed into one of India’s top biopharmaceutical firms. More than 120 nations sell Biocon’s products, and the business places a big emphasis on R&D. A leader in the creation of biosimilars, less expensive variations of biologic medications, is Biocon.
Services
Biocon offers a wide range of services, including:
- Generic drug manufacturing
- Biosimilars development
- Research and development
- Contract manufacturing
- Clinical trials
Founder
Kiran Mazumdar-Shaw is the founder and chairperson of Biocon. She is a recipient of the Padma Bhushan, India’s third-highest civilian award. Mazumdar-Shaw is also a member of the World Economic Forum’s Global Agenda Council on Biomedicine.
Achievements
Biocon has been recognized for its achievements in a number of areas, including:
- Innovation: Biocon has been recognized for its innovation in the field of biopharmaceuticals. The company has a strong track record of developing new products and technologies.
- Sustainability: Biocon is committed to sustainability. The company has a number of initiatives in place to reduce its environmental impact.
- Corporate social responsibility: Biocon is committed to corporate social responsibility. The company supports a number of initiatives to improve the lives of people in India and around the world.
Future Plans
Biocon is committed to continued growth and innovation. The company plans to expand its product portfolio and geographic reach. Biocon is also investing in research and development to develop new products and technologies.
If you have got any new information to add on regarding (Company’s name or anything), Let us update the same at [email protected]